BioLife Plasma Services
The Process Technology & Innovation Lead DS Upstream defines and drives the global technology and innovation strategy for Drug Substance Upstream manufacturing across Takeda's network. This role leads the development and deployment of advanced process technologies, digital solutions, and innovative manufacturing capabilities to enhance operational performance and sustainability. The position involves strategic planning, portfolio governance, and cross-functional collaboration to shape the future of manufacturing.
Headquarters
Bannockburn, Illinois, United States
Company Size
5001-10000 employees
BioLife Plasma Services operates a network of plasma collection centers that collect donated human plasma used to manufacture life‑saving plasma‑derived therapies. The company focuses on donor safety and convenience, offering screening, regulated collection procedures, appointment scheduling, and compensation/rewards to encourage repeat donations. BioLife partners with biopharmaceutical manufacturers and maintains rigorous quality and regulatory standards to supply plasma for treatments such as immune deficiencies, bleeding disorders, and other therapeutic uses.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for BioLife Plasma Services.
Associate Director, Drug Substance Manufacturing – Upstream Process
Vera Therapeutics, Inc.
Process Engineer Upstream Manufacturing
Roche
(Sr.) Process Engineer, MSAT - Upstream
Aurabiosciences
Senior Process Engineer – Manufacturing Science and Technology (MSAT)
Verista, Inc.
MSAT Bio DS Process Lead
City of Pierre, South Dakota
Director Process Development - Purification Process Engineering
Amgen